MAPT and Alzheimer disease: We and others have previously shown that soluble Aβ aggregates directly isolated from human AD brains disrupt synaptic plasticity and neurite integrity, induce tau phosphorylation, impair hippocampal long-term potentiation (LTP), and induce neuronal hyperactivation and cognitive decline [19–23].